Immunoglobulin Kinetics And Infection Risk After Long-Term Inebilizumab Treatment For NMOSD

Greenberg, B; She, D; Ratchford, JN; Katz, E; Cree, BA

MULTIPLE SCLEROSIS JOURNAL, 2021; 27 (1_SUPPL): 81